We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




"Code Ready” Defibrillator Available to Hospitals

By HospiMedica staff writers
Posted on 14 Dec 2006
A new defibrillator offers tools that can help clinicians improve cardiopulmonary resuscitation (CPR) performance and deployment of pacing and defibrillation therapy. More...


This R Series defibrillator, intended for hospital use, includes one electrode set through which clinicians can monitor, pace, defibrillate, and get real-time feedback on chest compressions, also known as Real CPR Help. Besides shock delivery, the system checks more than 40 measures of readiness, including the presence of the correct cables and electrodes, the type of electrodes, and other important electronics.

A main feature of the R Series is See-Thru CP, a function that helps clinicians minimize interruptions in CPR performance. While viewing the electrocardiogram (ECG) on a monitor/defibrillator, artifact noises from chest compressions make it difficult to discern the presence of an organized heart rhythm unless compressions are halted. See-Thru CPR filters out this artifact so clinicians can view an underlying rhythm without stopping chest compressions.

A visual aid known as the CPR Index, along with audible prompts (i.e., "Push Harder” and "Good Compressions”), allows clinicians to see how well they are performing the rate and depth of chest compressions in real time and quickly adjust their compressions to improve blood flow. All CPR performance data and the entire resuscitation record, including the ECG, can be downloaded and reviewed for quality assurance and training purposes.

The R Series defibrillator is a product of Zoll Medical (Chelmsford, MA, USA).

"Hospital clinicians know that the worst time to find out a defibrillator isn't working is during a cardiac arrest event,” said Richard A. Packer, president and CEO of Zoll. "The R Series is the first and only ‘Code-Ready' defibrillator. It raises the bar on what clinicians will expect from their defibrillators.”



Related Links:
Zoll Medical

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Morcellator
TCM 3000 BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.